Package Insert: Information for the User
Doneka 5mg tablets
Lisinopril
Read this package insert carefully before you start taking this medicine, as it contains important information for you.
Doneka pertains to a group of medications known as angiotensin-converting enzyme inhibitors (ACE inhibitors).
Doneka isindicated for:
Do not take Doneka if:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Doneka.
Be extra careful with Doneka:
Inform your doctor in all these cases, as you may need a dose adjustment or discontinue Doneka medication.
Stop taking Doneka and seek medical assistance immediatelyif you have difficulty breathing or swallowing with or without swelling of the face, lips, tongue, and/or throat.
Inform your doctor if you are to be admitted to a hospital for a surgical procedure. Inform your doctor or dentist that you are taking Doneka before they administer a local or general anesthetic.
Children
Doneka is not recommended for use in children as the information on safety and efficacy in this age group is limited.
Other medications and Doneka
Inform your doctor or pharmacist if you are taking, or have recently taken, any other medication, including those purchased without a prescription.
These instructions may also apply to medications that have been used before or may be used afterwards.
Certain medications may interact with Donekain these cases, it may be necessary to change the dose or discontinue treatment with one of them.
It is essential to inform your doctor if you are taking or have recently taken any of the following medications:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication. Normally, your doctor will advise you to stop taking lisinopril before becoming pregnant or as soon as you know you are pregnant and recommend taking another medication instead of lisinopril. Lisinopril is not recommended in the first months of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious damage to the baby if used after the third month of pregnancy.
Lisinopril is not recommended for breastfeeding mothers, and your doctor may choose another treatment for you if you wish to breastfeed your baby, especially if it is a newborn or premature.
Driving and operating machinery
It is unlikely that Doneka tabletswill affect your ability to drive vehicles or use machines; however, if you notice symptoms of dizziness or fatigue, avoid performing tasks that require special attention until you know how you tolerate the medication.
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor. If in doubt, ask your doctor or pharmacist. Remember to take your medication.
Your doctor will tell you how many tablets to take per day and the duration of your treatment with Doneka. Do not discontinue treatment beforehand.
The recommended dose is:
Adults
The usual initial recommended dose is 10 mg once a day.
The usual long-term dose is 20 mg once a day.
The usual initial recommended dose is 2.5 mg once a day.
The usual long-term dose is 5 mg up to a maximum of 35 mg once a day.
The usual initial recommended dose is 5 mg on the first and second day after the infarction, followed by 10 mg once a day.
The usual dose is 10 mg or 20 mg once a day.
Patients with renal function impairment
Your doctor will adjust the dose.
Administration form:
If you estimate that the action of Doneka is too strong or too weak, consult your doctor or pharmacist.
If you take more Doneka than you should:
If you take more Doneka than you should, consult your doctor or pharmacist immediately.
The most frequent symptoms in case of overdose are: hypotension, shock, renal insufficiency, hyperventilation, tachycardia, palpitations, bradycardia, dizziness, anxiety, and cough.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service. Phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Doneka:
Do not take a double dose to compensate for the missed dose and wait for the next administration.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The following side effects have been described according to the following frequency categories:
Frequent:less than 1 in 10 but more than 1 in 100 patients
Infrequent:less than 1 in 100 but more than 1 in 1,000 patients
Rare:less than 1 in 1,000 patients but more than 1 in 10,000 patients
Very rare:less than 1 in 10,000 patients
Blood and lymphatic system disorders: | |
Rare: | decreased hemoglobin (a blood protein), decreased hematocrit (proportion of cells in the blood). |
Very rare: | bone marrow depression, anemia, thrombocytopenia (easier bleeding), changes in some cells or blood components. |
Metabolism and nutritional disorders: | |
Very rare: | decreased blood glucose. |
Nervous system and psychiatric disorders: | |
Frequent: | dizziness, headache |
Infrequent: | mood changes, numbness and/or tingling in certain limbs, vertigo, changes in the taste of things, sleep disorders. |
Rare: | confusion. |
Cardiac and vascular disorders: | |
Frequent: | dizziness or lightheadedness when standing up quickly. |
Infrequent: | myocardial infarction or stroke, palpitations, rapid heartbeats, numbness and spasms in the fingers of the hands, followed by heat and pain (Raynaud's phenomenon). |
Respiratory disorders: | |
Frequent | Cough |
Infrequent: | rhinitis. |
Very rare: | shortness of breath, sinusitis, lung inflammation |
Gastrointestinal disorders: | |
Frequent: | diarrhea, vomiting. |
Infrequent: | nausea, abdominal pain and indigestion. |
Rare: | dry mouth. |
Very rare: | inflammation of the liver or pancreas, jaundice (yellow discoloration of the skin and/or eyes). |
Skin disorders: | |
Infrequent: | eruption, itching. |
Rare: | intense skin burning (with blisters), hair loss, psoriasis, allergic reaction (angioedema) characterized by swelling of the face, limbs, lips, tongue, and/or larynx. |
Very rare: | sweating, severe skin disorders (symptoms may include redness, blisters, and peeling). |
In some cases, fatigue or sore throat may occur, which may be accompanied by fever, joint and muscle pain, swelling of the joints or glands, or sensitivity to sunlight.
Renal and urinary disorders: | |
Frequent: | changes in kidney function. |
Rare: | increased urea in the urine, acute renal insufficiency. |
Very rare: | pain or inability to urinate. |
Reproductive and breast disorders: | |
Infrequent: | impotence. |
Rare: | development of breasts in males. |
General disorders: | |
Infrequent: | fatigue, tiredness. |
Laboratory determinations: | |
Infrequent: | increased blood urea, increased creatinine in the blood, increased liver enzymes, increased potassium in the blood. |
Rare: | increased bilirubin in the blood, decreased sodium in the blood. |
If you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not mentioned in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's website: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Doneka
Appearance of the product and contents of the packaging
Doneka 5 mg is presented in the form of orange-colored, round, biconvex tablets with a notch on one face and the mark "5" on the other. Each package contains 60 tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Responsible for manufacturing:
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Last review date of this leaflet: September 2016
The detailed information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.